Table 5.

Comparative Clinical and Pathologic Characteristics of Patients with and without PTEN Loss.

	Cases with PTEN loss	Cases with no PTEN loss	P
No. of cases	15	38
Detection on biopsy method, n (%)
Targeted cores	14 (93%)
Standard cores	7 (47%)
Targeted and standard cores	6 (40%)
Age (y), mean ± SD	66 ± 8	65 ± 8	.66
Race, n (%)			1.0
African American	2 (15%)	8 (21%)
White	11 (85%)	30 (79%)	.36
GG, n (%)
1	6 (40%)	22 (58%)
2	9 (60%)	16 (42%)
PSA, mean ± SD	6.3 ± 4.0	6.1 ± 3.1	.79
PIRADS, n (%)			.36
3	1 (7%)	9 (24%)
4	8 (53%)	19 (50%)
5	6 (40%)	10 (26%)	.053
Treatment, n (%)
Active surveillance	5 (33.3%)	25 (65.8%)
Radiation therapy	5 (33.3%)	4 (10.5%)
Radical prostatectomy	3 (20.0%)	5 (13.2%)
Unknown	2 (13.3%)	4 (10.5%)